| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $943.5M | +19.3% |
| R&D Expense | $48.8M | +38.0% |
| SG&A Expense | $111.8M | +77.6% |
| Operating Income | $123.7M | -12.9% |
| Pre-tax Income | -$22.5M | +64.7% |
| Income Tax | -$3.4M | +72.6% |
| Net Income | -$19.1M | +62.7% |
| EPS (Basic) | -$0.13 | +69.0% |
| EPS (Diluted) | -$0.13 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $182.1M | +411.9% |
| Accounts Receivable | $145.2M | +15.2% |
| Current Assets | $371.0M | +67.1% |
| Total Assets | $4.58B | -0.1% |
| Current Liabilities | $145.6M | +17.9% |
| Long-term Debt | $1.24B | -43.5% |
| Total Liabilities | $1.50B | -40.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $169.8M | +229.9% |
| Investing Cash Flow | -$27.3M | +55.7% |
| Financing Cash Flow | $16.7M | +197.1% |
| +69.0% |
| Stockholders' Equity |
| $3.08B |
| +50.2% |